The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and immune responses using anti-CD3 x anti-EGFR bispecific antibody armed T cells (BATs) for locally advanced or metastatic pancreatic cancer.
 
Lawrence G. Lum
Stock and Other Ownership Interests - TransTarget
Consulting or Advisory Role - Rapa Therapeutics
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - I was inventor for "In situ immunization" patent license from Roger Williams Hospital to Transtarget.
 
Tri Minh Le
No Relationships to Disclose
 
Minsig Choi
No Relationships to Disclose
 
Archana Thakur
No Relationships to Disclose
 
Matthew Reilley
Travel, Accommodations, Expenses - Deciphera; Xencor
 
Paul Raymond Kunk
Consulting or Advisory Role - Exelixis
Research Funding - Array BioPharma; Exelixis
 
Abhinav Deol
Consulting or Advisory Role - Agios; Kite/Gilead; Novartis
 
Karen K. Ballen
No Relationships to Disclose
 
Tamila L. Kindwall-Keller
No Relationships to Disclose
 
Dana Schalk
No Relationships to Disclose
 
Ewa Kubicka
No Relationships to Disclose
 
Manley Huang
Leadership - TransTarget
Stock and Other Ownership Interests - TransTarget
Consulting or Advisory Role - TransTarget
Research Funding - TransTarget
 
Philip Agop Philip
Honoraria - Amgen; ASLAN Pharmaceuticals; Bayer; Biologics; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Lexi Pharma; Merck; Novartis; Rafael Pharmaceuticals; Sanofi
Consulting or Advisory Role - Celgene; Halozyme; Ipsen; Merck; Merrimack; novartis; Rafael Pharmaceuticals
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Celgene; Ipsen; Merck
Research Funding - Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Genentech (Inst); halozyme (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); QED Therapeutics (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); tyme (Inst); TYME (Inst)
Other Relationship - Halozyme
 
Hussein Aoun
No Relationships to Disclose
 
Gregory Dyson
No Relationships to Disclose
 
Qin Liu
No Relationships to Disclose
 
Anthony Frank Shields
Consulting or Advisory Role - Caris Life Sciences; ImaginAb; TransTarget
Speakers' Bureau - GE Healthcare
Research Funding - Bayer; Boehringer Ingelheim; Caris Life Sciences; Daiichi Sankyo; Eisai; Exelixis; H3 Biomedicine; Halozyme; ImaginAb; Incyte; Inovio Pharmaceuticals; Lexicon; LSK BioPharma; Plexxikon; Taiho Pharmaceutical; Torque; Xencor
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget